Teladoc stock closed down 1.36%, but analysts show positivity towards its business operations.

From Nasdaq: 2025-03-03 18:15:04

Teladoc (TDOC) closed at $9.43, down 1.36% from the previous day, outperforming the S&P 500’s 1.76% loss. Over the past month, TDOC shares dropped 5.91%, lower than the Medical sector’s 1.11% gain. Analysts expect TDOC to report an EPS of -$0.34, with revenue forecasted at $617.45 million for the upcoming earnings disclosure.

The Zacks Consensus Estimates project TDOC to earn -$0.94 per share and generate $2.51 billion in revenue for the full year. Recent analyst estimate revisions reflect positivity towards TDOC’s business operations. The Zacks Rank system rates TDOC as a #3 (Hold) stock, with a 4.92% increase in the Zacks Consensus EPS estimate in the past month.

The Medical Services industry, part of the Medical sector, holds a Zacks Industry Rank of 83, placing it within the top 34% of industries. The Zacks Industry Rank, based on individual stock Zacks Ranks, shows that top-rated industries outperform the bottom half by a 2 to 1 factor. For more information, visit Zacks.com.

For investors seeking top stock picks, Zacks has released the “Zacks Top 10 Stocks for 2025” portfolio, featuring consistently successful stocks with enormous potential. Handpicked by Zacks Director of Research, this portfolio has outperformed the S&P 500 significantly. Get early access to these top stocks for 2025 today.



Read more at Nasdaq: Teladoc (TDOC) Stock Moves -1.36%: What You Should Know